Clincosm LogoSign in Get a demo

Bipolar Research And Innovation Network - BRAIN

Sponsor
Norwegian University of Science and Technology (Other)
Overall Status
Recruiting
CT.gov ID
NCT00201526
Collaborator
University of Oslo (Other)
3,000
Enrollment
1
Location
324
Anticipated Duration (Months)
9.3
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

To describe the broad spectrum of Bipolar Disorder patients admitted to out-patient and in-patient psychiatric departments in Norway. Include all admitted Bipolar patients both with and without co-morbid disorders.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Norway is both social, genetically and culturally a homogeneous society. The health service is public and has a nearly total responsibility for psychiatric care in given catchment areas. This provides excellent opportunities to describe the frequencies and patterns of the broad spectrum of bipolar illness, including co-morbid substance use disorders, to follow the patients for several years and to do molecular genetic mapping.

    Methods: Participating centers consist of outpatient clinics and hospital departments from different parts of Norway and one third-line clinic with referrals from all over Norway. Specifically trained clinicians in each center include bipolar patients systematically and perform the patient evaluation as part of their clinical duties. In addition, CT or MRI scans and EEG are performed and blood samples are collected for clinical chemistry screening and for DNA sampling.

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    3000 participants
    Observational Model:
    Case-Only
    Time Perspective:
    Cross-Sectional
    Official Title:
    Bipolar Research And Innovation Network - BRAIN
    Actual Study Start Date :
    Jan 1, 2003
    Anticipated Primary Completion Date :
    Jan 1, 2030
    Anticipated Study Completion Date :
    Jan 1, 2030

    Outcome Measures

    Primary Outcome Measures

    1. characterization of bipolar disorders [15 years]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    N/A and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • All admitted patients giving written consent to participate in the study
    Exclusion Criteria:
    • Patients without competence for consent.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Medical Faculty, Norwegian University of Science And Technology Trondheim Norway 7441

    Sponsors and Collaborators

    • Norwegian University of Science and Technology
    • University of Oslo

    Investigators

    • Principal Investigator: Gunnar Morken, PhD MD, Norwegian University of Science and Technology

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Norwegian University of Science and Technology
    ClinicalTrials.gov Identifier:
    NCT00201526
    Other Study ID Numbers:
    • BRAIN-04
    First Posted:
    Sep 20, 2005
    Last Update Posted:
    Apr 4, 2022
    Last Verified:
    Apr 1, 2022
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Norwegian University of Science and Technology
    Bipolar Disorder
    Additional relevant MeSH terms:
    Bipolar Disorder

    Study Results

    No Results Posted as of Apr 4, 2022